Organogenesis (ORGO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Jun, 2026Opening remarks and agenda
The meeting was called to order by the Chair, who welcomed attendees to the 2026 virtual annual meeting and introduced the board and management team members present virtually.
The agenda included the election of directors, advisory vote on executive compensation, and ratification of the independent auditor.
Board and executive committee updates
The board consists of nine nominees for re-election and one preferred director, totaling ten directors for the next term.
No other nominations for director positions were received from stockholders.
Shareholder proposals
No additional matters or proposals were submitted by stockholders for consideration at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Organogenesis
- Q1 2026 revenue fell 58% and net loss widened amid CMS-driven disruption and restructuring.ORGO
Q1 20268 May 2026 - Director elections, executive pay, and auditor ratification headline a governance-focused annual meeting.ORGO
Proxy filing30 Apr 2026 - Record 2025 results, but 2026 revenue expected to decline amid CMS-driven disruption before recovery.ORGO
Q4 20257 Apr 2026 - Strong product innovation and regulatory adaptation drive growth amid reimbursement shifts.ORGO
2024 Cantor Fitzgerald Global Healthcare Conference3 Feb 2026 - Q2 revenue up 11% to $130.2M, but net loss widened on impairments and write-downs.ORGO
Q2 20241 Feb 2026 - Q3 net income rose to $12.3M on 6% revenue growth; 2024 outlook strong despite regulatory risks.ORGO
Q3 202414 Jan 2026 - Regulatory changes, new launches, and a robust pipeline position the company for strong future growth.ORGO
Cantor Global Healthcare Conference 20255 Jan 2026 - Regenerative medicine firm seeks to raise $250M and enable resale of 50M shares by holders.ORGO
Registration Filing16 Dec 2025 - Registering 130,000 Series A Preferred and 34.3M Common Shares for resale by private investors.ORGO
Registration Filing16 Dec 2025